
浏览全部资源
扫码关注微信
400037 重庆,陆军军医大学(第三军医大学)第二附属医院病理科
[郭乔楠,博士,主任医师,教授,博士研究生导师。担任中国医师协会病理科医师分会常务委员、中国研究型医院协会超微与分子病理学专委会常务委员、重庆市医师协会病理科医师分会会长,入选重庆市学科技术带头人。主持国家自然科学基金面上项目、重庆市自然科学基金重点项目等10余项。为《第三军医大学学报》《局解手术学杂志》常务编委,Oncology Letters编委。在SCI收录期刊发表论文20余篇。主要从事外科病理诊断学及肿瘤分子病理学等方面的研究。E-mail:qiaonan85@263.net GUO Qiaonan, E-mail: qiaonan85@263.net
收稿:2021-12-07,
修回:2021-12-12,
纸质出版:2022-01-15
移动端阅览
郭乔楠, 吕杨帆. 研精覃思,见微知著——人工智能开启精准病理诊断新时代[J]. 陆军军医大学学报, 2022,44(1):60-63.
Qiaonan GUO, Yangfan LYU. Details determine success, a feather shows the way the wind blows: Artificial intelligence opens a new era of precise pathological diagnosis[J]. Journal of Army Medical University, 2022, 44(1): 60-63.
郭乔楠, 吕杨帆. 研精覃思,见微知著——人工智能开启精准病理诊断新时代[J]. 陆军军医大学学报, 2022,44(1):60-63. DOI: 10.16016/j.1000-5404.202112055.
Qiaonan GUO, Yangfan LYU. Details determine success, a feather shows the way the wind blows: Artificial intelligence opens a new era of precise pathological diagnosis[J]. Journal of Army Medical University, 2022, 44(1): 60-63. DOI: 10.16016/j.1000-5404.202112055.
精准医疗时代,病理学作为基础医学与临床医学的桥梁学科,担负着为疾病个体化治疗提供关键信息的重要任务。精准病理诊断为病理医师的工作带来巨大挑战,人工智能“赋能”病理诊断,通过整合患者临床信息、组织病理学影像、多组学信息,有效辅助精准病理诊断、预测患者预后、分子改变等,有望在精准病理诊断的新时代发挥至关重要的作用,开启精准病理诊断新时代。
In the era of precision medicine
pathology
as a bridge between basic and clinical medicine
undertakes the important task of providing key information for the individualized treatment of diseases. Accurate pathological diagnosis of pathology brings huge challenges for pathological doctors. Artificial intelligence facilitates pathological diagnosis
through the integration of the patient's clinical information
histopathological images and multi-omics information
which could effectively assist pathological precision diagnosis
prediction
and molecular changes
etc. Artificial intelligence is expected to play a vital role in precise pathological diagnosis and opens a new era of accurate pathological diagnosis.
梁英杰, 张芬芬, 董愉. 我国病理学技术六十年发展的现状和展望[J]. 中华病理学杂志, 2015, 44(7): 466-468.
LIANG Y J, ZHANG F F, DONG Y. Present situation and prospect of the development of pathology in China in 60 years[J]. Chin J Pathol, 2015, 44(7): 466-468.
吴秉铨. 病理学科发展的现在和未来[J]. 中华病理学杂志, 1999, 28(5): 325.
WU B Q. Present and future of the development of pathology[J]. Chin J Pathol, 1999, 28(5): 325.
孙耘田. 细胞病理学技术进展评述[J]. 中华病理学杂志, 2003, 32(3): 96-98.
SUN Y T. Review of advances in cytopathology[J]. Chin J Pathol, 2003, 32(3): 96-98.
舒仪经, 阚秀. 我国细胞病理学的回顾与展望[J]. 中华病理学杂志, 2005, 34(10): 20-22.
SHU Y J, KAN X. Review and prospect of cytopathology in China[J]. Chin J Pathol, 2005, 34(10): 20-22.
张国民. 病理学科可持续发展的探讨[J]. 中华医院管理杂志, 2002, 18(3): 65-66.
ZHANG G M. Exploration into the sustainable development of the discipline of pathology[J]. Chin J Hosp Adm, 2002, 18(3): 65-66.
谢丰培, 石宇, 李连宏, 等. 中国精准医学发展需要大力加速病理学科建设[J]. 临床与实验病理学杂志, 2018, 34(1): 4-6. DOI: 10.13315/j.cnki.cjcep.2018.01.002.
XIE F P, SHI Y, LI L H, et al . The development of precision medicine in China needs to accelerate the construction of pathology[J ] . Chin J Clin Exp Pathol, 2018, 34(1): 4-6. DOI: 10.13315/j.cnki.cjcep.2018.01.002.
周庚寅, 高鹏. 分子病理学的衍生——病理学发展轨迹之必然[J]. 山东大学学报(医学版), 2011, 49(10): 63-66.
ZHOU G Y, GAO P. Derivation of molecular pathology—The necessity of pathologic development[J]. J Shandong Univ Heal Sci, 2011, 49(10): 63-66.
张卉, 李瑞玉, 梁智勇. 病理学向分子病理时代迈进[J]. 中国科学: 生命科学, 2021, 51(8): 1101-1106.
ZHANG H, LI R Y, LIANG Z Y. Molecular pathology: the new era of clinical pathology[J]. Sci Sin Vitae, 2021, 51(8): 1101-1106.
张波. 精准医疗时代的病理学发展[J]. 协和医学杂志, 2017, 8(Z1): 117-121.
ZHANG B. Development of pathology in coming era of precision medicine[J]. Med J Peking Union Med Coll Hosp, 2017, 8(Z1): 117-121.
步宏. 积极推动人工智能在病理学的应用[J]. 中华病理学杂志, 2021, 50(4): 307-309. DOI: 10.3760/cma.j.cn112151-20210219-00148.
BU H. Promote the application of artificial intelligence in pathology[J]. Chin J Pathol, 2021, 50(4): 307-309. DOI: 10.3760/cma.j.cn112151-20210219-00148.
顾松, 鲁浩达, 谢嘉伟, 等. 计算病理及其对精准医学的价值[J]. 中华病理学杂志, 2021, 50(8): 851-855. DOI: 10.3760/cma.j.cn112151-20201130-00878.
GU S, LU H D, XIE J W, et al . Computational pathology and its contributions to precision medicine[J ] . Chin J Pathol, 2021, 50(8): 851-855. DOI: 10.3760/cma.j.cn112151-20201130-00878.
SONG Z, ZOU S, ZHOU W, et al . Clinically applicable histopathological diagnosis system for gastric cancer detection using deep learning[J ] . Nat Commun, 2020, 11(1): 4294. DOI: 10.1038/s41467-020-18147-8.
KOMORI T. AI Neuropathologist: an innovative technology enabling a faultless pathological diagnosis?[J]. Neuro Oncol, 2021, 23(1): 1-2. DOI: 10.1093/neuonc/noaa229.
SHEN B, ZHANG Z, SHI X, et al . Real-time intraoperative glioma diagnosis using fluorescence imaging and deep convolutional neural networks[J ] . Eur J Nucl Med Mol Imaging, 2021, 48(11): 3482-3492. DOI: 10.1007/s00259-021-05326-y.
CHEN P S, LI Y P, NI H F. Morphology and evaluation of renal fibrosis[J]. Adv Exp Med Biol, 2019, 1165: 17-36. DOI: 10.1007/978-981-13-8871-2_2.
WAN T, CAO J J, CHEN J H, et al . Automated grading of breast cancer histopathology using cascaded ensemble with combination of multi-level image features[J ] . Neurocomputing, 2017, 229: 34-44. DOI: 10.1016/j.neucom.2016.05.084.
NIELSEN T O, LEUNG S C Y, RIMM D L, et al . Assessment of Ki67 in breast cancer: updated recommendations from the international Ki67 in breast cancer working group[J ] . J Natl Cancer Inst, 2021, 113(7): 808-819. DOI: 10.1093/jnci/djaa201.
SKREDE O J, DE RAEDT S, KLEPPE A, et al . Deep learning for prediction of colorectal cancer outcome: a discovery and validation study[J ] . Lancet, 2020, 395(10221): 350-360. DOI: 10.1016/s0140-6736(19)32998-8.
KULKARNI P M, ROBINSON E J, SARIN PRADHAN J, et al . Deep learning based on standard H & E images of primary melanoma tumors identifies patients at risk for visceral recurrence and death[J ] . Clin Cancer Res, 2020, 26(5): 1126-1134. DOI: 10.1158/1078-0432.ccr-19-1495.
LU C, KOYUNCU C, C ORREDOR G, et al . Feature-driven local cell graph (FLocK): New computational pathology-based descriptors for prognosis of lung cancer and HPV status of oropharyngeal cancers[J ] . Med Image Anal, 2021, 68: 101903. DOI: 10.1016/j.media.2020.101903.
CORREDOR G, WANG X X, ZHOU Y, et al . Spatial architecture and arrangement of tumor-infiltrating lymphocytes for predicting likelihood of recurrence in early-stage non-small cell lung cancer[J ] . Clin Cancer Res, 2019, 25(5): 1526-1534. DOI: 10.1158/1078-0432.CCR-18-2013.
王荃, 沈勤, 张泽林, 等. 基于深度学习和组织形态分析的肺癌基因突变预测[J]. 生物医学工程学杂志, 2020, 37(1): 10-18.
WANG Q, SHEN Q, ZHANG Z L, et al . Prediction of gene mutation in lung cancer based on deep learning and histomorphology analysis[J ] . J Biomed Eng, 2020, 37(1): 10-18.
VAIDYA P, BERA K, GUPTA A, et al . CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in stage Ⅰ, Ⅱ resectable non-small cell lung cancer: a retrospective multicohort study for outcome prediction[J ] . Lancet Digit Health, 2020, 2(3): e116-e128. DOI: 10.1016/s2589-7500(20)30002-9.
CHEN R J, LU M Y, WANG J W, et al . Pathomic fusion: an integrated framework for fu sing histopathology and genomic features for cancer diagnosis and prognosis[J ] . IEEE Trans Med Imaging, 2020. [Online ahead of print ] . DOI:10.1109/TMI.2020.3021387.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621